Waters Corporation to Present at the Jefferies Global Healthcare Conference in London

Waters Corporation (NYSE:WAT), a leading global provider of analytical instruments and separations technologies, has announced that its President and CEO, Udit Batra, Ph.D., will participate in a critical fireside chat at the Jefferies Global Healthcare Conference in London. This event is scheduled for November 18, 2025, at 2:30 PM GMT (9:30 AM ET). The chat will be accessible via a live webcast on the Waters Investor Relations website, with a replay available for 90 days post-event.

With a history spanning over 65 years, Waters Corporation specializes in creating technology solutions that ensure the efficacy of medicines, the safety of food, and the purity of water. Their innovative products and services are indispensable across various sectors, including life sciences, materials science, and environmental protection. The company operates in over 100 countries and boasts a dedicated workforce of more than 7,600 employees who engage collaboratively with customers in laboratories, manufacturing facilities, and healthcare settings.

The Jefferies Global Healthcare Conference serves as an essential platform for Waters Corporation to communicate its strategies and advancements in the healthcare sector, reflecting its commitment to science and technology that enhance the quality of life. Investors and stakeholders keen to understand Waters' growth trajectory and contributions to healthcare innovation are encouraged to tune into the webcast.

For more detailed information or to participate in the live feedback, interested parties can visit the Events & Presentations section of the Waters Investor Relations website. This engagement underscores Waters Corporation’s dedication to transparency and investor communication as it continues to push the boundaries of scientific discovery and application.

As Waters Corporation (NYSE: WAT) prepares for its presentation at the Jefferies Global Healthcare Conference in London on November 18, 2025, investors should closely monitor the company’s strategic initiatives and market positioning within the healthcare ecosystem. Waters is renowned for its leadership in analytical instruments and separations technologies, which are essential for the life sciences, food safety, and environmental industries. These core sectors are experiencing heightened demand due to increased regulatory scrutiny and a greater focus on health and safety amid ongoing global health challenges.

Given the current landscape, it is advisable for investors to focus on Waters’ recent advancements in technology and partnerships that could enhance its market share. The company's commitment to innovation, with a significant portion of revenue reinvested into research and development, positions it well for sustained growth. As regulatory requirements evolve, Waters' expertise in developing solutions that ensure compliance and quality will likely become increasingly valuable.

Furthermore, the live webcast of the event allows investors to gather insights directly from Waters' leadership, notably Udit Batra, Ph.D. His outlook on upcoming product launches and market trends could offer critical cues for future performance.

While the overall market dynamics may present potential volatility, Waters Corporation’s solid fundamentals and strategic positioning within vital industry sectors suggest that it remains a compelling investment opportunity. For those considering entry or increased exposure to health technology, monitoring the outcomes of this presentation and evaluating the company's subsequent performance can provide pivotal information for informed investment decisions. As the healthcare market continues to expand, Waters' integral role in improving analytical capabilities will likely bolster its business resilience and growth trajectory.